Did Xarelto’s Makers Fail to Properly Warn Users of Bleeding Risks?

Another lawsuit has been filed concerning bleeding risks associated with blood thinner Xarelto, according to The Madison-St. Clair Record. A woman who claims that taking the drug has “created an inability for her blood to congeal in a timely manner” is bringing the suit, which has been filed against Janssen Research and Development and Bayer Healthcare Pharmaceuticals, the makers of Xarelto.

In her suit, the woman, who was taking Xarelto to prevent strokes, claims that the drug left her without the ability for her blood to clot in a timely manner. She says that the makers of Xarelto never included information about the drug’s bleeding risks, including gastrointestinal bleeding and bleed outs that require transfusions, in promotional materials.

According to the suit, Xarelto’s drug makers failed to admit its anti-coagulation effects in 2011 promotional materials, resulting in a reported 2,081 serious adverse events and 151 deaths in 2012 involving patients who took the drug. The woman is seeking $4.35 million in her suit, accusing Xarelto’s drug makers of common law fraud, negligent misrepresentation, intentional and negligent infliction of emotional distress and strict product liability.

How Can a Lawsuit Help Stop Dangerous Drug Makers from Hurting Others?

If you have been following our blog lately, you know how concerned we’ve become with Xarelto and the dangers it is posing to its users. Filing a defective drug lawsuit is just as much about protecting others from getting hurt as it is about making those at fault pay for what they have put you and your family through.

We are dedicated to helping victims and their families bring those responsible for their pain and suffering to justice. Continue to follow our blog and explore our website for more information about how our pharmaceutical litigation attorneys can help you.

Colson Hicks Eidson – Injury Attorneys

Source: http://madisonrecord.com/news/268779-xarelto-makers-face-claims-over-drugs-alleged-inability-to-timely-congeal-blood



Leave a Reply

Your email address will not be published. Required fields are marked *